ABSTRACT
Smoking is an important public health problem that costs over 430,000 lives a year in the United States alone [1]. When compared to placebo, the first-line treatments, including nicotine replacement therapies (NRTs) and sustained-release bupropion, approximately double the long-term success rate for smoking cessation [2-4].
